Hostname: page-component-76d6cb85b7-2r2wp Total loading time: 0 Render date: 2026-07-17T00:42:47.621Z Has data issue: false hasContentIssue false
  • English
  • Français

Herbal products: active constituents, modes of action and quality control

Published online by Cambridge University Press:  14 December 2007

Ron B.H. Wills ,
Kerry Bone  and
Michelle Morgan
Ron B.H. Wills*
Affiliation:
Centre for Food Industry Research and Development, Faculty of the Central Coast, University of Newcastle, Ourimbah, NSW 2258, Australia
Kerry Bone
Affiliation:
MediHerb, Warwick Qld 4370, Australia
Michelle Morgan
Affiliation:
MediHerb, Warwick Qld 4370, Australia
*
*Corresponding author: Dr Ron B. H. Wills, fax +612 46484140, email ftrbhw@cc.newcastle.edu.au
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

An overview is given of the current position of medicinal herbs in general in relation to usage, market and production, types of pharmacological activity and how they differ from conventional drugs. The increasing importance of quality and manufactured products is also discussed. A more detailed consideration of these issues is given in relation to echinacea, valerian and St John's wort as these herbs are well studied, are market leaders and have widespread community usage.

Keywords

Herbal productsEchinaceaValerianSt John's wort

Information

Type
Research Article
Information
Nutrition Research Reviews , Volume 13 , Issue 1 , June 2000 , pp. 47 - 77
Copyright
Copyright © CABI Publishing 2000

References

Andreatini, R & Leite, JR (1994) Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal. European Journal of Pharmacology 260, 233–235.CrossRefGoogle ScholarPubMed
Bannerman, R, Burton, J & Wen-Chieh, C (1983) Traditional Medicine and Health Care Coverage, a Reader for Health Administrators and Practitioners. Geneva: World Health Organization.Google Scholar
Bauer, VR, Jurcic, K, Puhlmann, J & Wagner, H (1988) Immunologic in vivo and in vitro studies on Echinacea extracts. Arzneimittelforschung 38, 276–281.Google ScholarPubMed
Bauer, R, Remiger, P, Jurcic, K & Wagner, H (1989) Influence of Echinacea extracts on phagocytic activity. Zeitschrift für Phytotherapie 10, 43–48.Google Scholar
Bauer, R & Wagner, H (1990) Echinacea. Handbuch für Ärzte, Apotheker und andere Naturwissenschaftler (Echinacea. Handbook for doctors, pharmacists and researchers). Stuttgart: Wissenschaftliche Verlagsgesellschaft.Google Scholar
Bauer, R & Wagner, H (1991) Echinacea species as potential immunostimulatory drugs. In Economic and Medicinal Plant Research, vol. 5, pp. 253–321 [Wagner, H and Farnsworth, NR, editors]. London: Academic Press.Google Scholar
Bendel, R, Bendel, V, Renner, K, Carstens, V & Stolze, K (1989) Additional treatment with Esberitox N in patients with chemo-radiotherapy treatment of advanced breast cancer. Onkologie 12,Suppl., 32–38.Google ScholarPubMed
Bendel, R, Bendel, V, Renner, K & Stolze, K (1988) Supplementary treatment with Esberitox of female patients undergoing curative adjuvant irradiation following breast cancer. Strahlentherapie und Onkologie 164, 278–283.Google ScholarPubMed
Bennett, RN & Wallsgrove, RM (1994) Tansley Review no. 72. Secondary metabolites in plant defence mechanisms. New Phytologist 127, 617–633.CrossRefGoogle Scholar
Berg, A, Northoff, H, Konig, D, Weinstock, C, Grathwohl, D, Parnham, MJ, Stuhlfauth, I & Keul, J (1998) Influence of Echinacin (EC31) treatment on the exercise-induced immune response in athletes. Journal of Drug Assessment 1, 625–638.Google Scholar
Beuscher, N, Bodinet, C, Willigmann, I & Egert, D (1995) Immune modulating properties of root extracts of different Echinacea species. Zeitschrift für Phytotherapie 16, 165–166.Google Scholar
Biber, A, Fischer, H, Romer, A & Chatterjee, SS (1998) Oral bioavailability of hyperforin from Hypericum extracts in rats and human volunteers. Pharmacopsychiatry 31,Suppl., 36–43.CrossRefGoogle ScholarPubMed
Birk, Y & Reri, I (1980) Saponins. In Toxic Constituents of Plant Foodstuffs, 2nd ed., pp. 166–167 [ Liener, IE, editor]. New York, NY: Academic Press.Google Scholar
Bos, R, Woerdenbag, HJ, Hendriks, H, Zwaving, JH, De Smet, PAGM, Tittel, G, Wikstrom, HV & Scheffer, JJC (1996) Analytical aspects of phytotherapeutic valerian preparations. Phytochemical Analysis 7, 143–151.3.0.CO;2-1>CrossRefGoogle Scholar
Bos, R, Woerdenbag, HJ & Scheffer, JJC (1993) Seasonal variation of the essential oil, valerenic acid derivatives and valepotriates in Valeriana officinalis roots. Planta Medica 59, Suppl. 7, A698.CrossRefGoogle Scholar
Bounthanh, C, Bergmann, C, Beck, JP, Haag-Berrurier, M & Anton, R (1981) Valepotriates, a new class of cytotoxic and antitumor agents. Planta Medica 41, 21–28.CrossRefGoogle ScholarPubMed
Brandt, L (1967) Studies on the phagocytic activity of neutrophilic leukocytes. Scandinavian Journal of Haematology. Supplementum 2, 1–126.Google ScholarPubMed
Braun, R, Dittmar, W, Hubner, E & Maurer, HR (1984) In vivo effect of valtrate/isovaltrate on bone marrow cells and the metabolic activity of the liver in mice. Planta Medica 50, 1–4.CrossRefGoogle Scholar
Bräunig, B, Dorn, M & Knick, E (1993) Enhancement of resistance in common cold by Echinacea purpureae radix. Zeitschrift für Phytotherapie 13, 7–13.Google Scholar
Bräunig, B & Knick, E (1993) Therapeutische erfahrungen mit Echinacea pallidae bei grippalen infekten. Naturheilpraxis 1, 72–75.Google Scholar
Brevoort, P (1998) The booming U.S. botanical market. A new overview HerbalGram no. 44, 33–48.Google Scholar
Brinkeborn, RM, Shah, DV & Degenring, FH (1999) Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. Phytomedicine 6, 1–5.CrossRefGoogle ScholarPubMed
British Herbal Medicine Association's Scientific Committee. (1983) British Herbal Pharmacopoeia, p. 115. Cowling:BHMA.Google Scholar
Brown, PD (1995) Glucosinolate-containing plant tissues as bioherbicides. Journal of Agricultural and Food Chemistry 43, 3070–3074.CrossRefGoogle Scholar
Bruneton, J (1995) Pharmacognosy, Phytochemistry, Medicinal Plants, p. 632. Paris: Lavoisier Publishing.Google Scholar
Burger, RA, Torres, AR, Warren, RP, Caldwell, VD & Hughes, BG (1997) Echinacea-induced cytokine production by human macrophages. International Journal of Immunopharmacology 19, 371–379.CrossRefGoogle ScholarPubMed
Büsing, KH (1952) Hyaluronidase inhibition by echinacin. Arzneimittelforschung 2, 464–467.Google Scholar
Bussotti, F, Gravano, E, Grossoni, P & Tani, C (1998) Occurrence of tannins in leaves of beech trees (Fagus sylvatica) along an ecological gradient, detected by histochemical and ultrastructural analyses. New Phytologist 138, 469–479.Google Scholar
Butterweck, V, Petereit, F, Winterhoff, H & Nahrsted, A (1998) Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Medica 64, 291–294.CrossRefGoogle ScholarPubMed
Cavadas, C, Araujo, I, Cotrim, MD, Amaral, T, Cunha, AP, Macedo, T & Ribeiro, CF (1995) In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittelforschung 45, 753–755.Google Scholar
Chatterjee, SS, Noldner, M, Koch, E & Erdelmeier, C (1998) Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry 31, 7–15.CrossRefGoogle ScholarPubMed
Cheminat, A, Zawatzky, R, Becker, H & Brouillard, R (1988) Caffeoyl conjugates from Echinacea species: structures and biological activity. Phytochemistry 27, 2787–2794.CrossRefGoogle Scholar
Coeugniet, EG & Elek, E (1987) Immunomodulation with Viscum album and Echinacea purpurea extracts. Onkologie 10, 27–33.Google Scholar
Coeugniet, EG & Kühnast, R (1986) Recurrent candidiasis. Adjuvant immunotherapy with several Echinacin formulations. Therapiewoche 36, 3352–3358.Google Scholar
Corrigan, D (1994) Indian Medicine for the Immune System. Surrey: Amberwood Publishing.Google Scholar
Curle, P, Kato, G & Hiller, KO (1996) Unpublished results, cited in Scientific Committee of ESCOP: ESCOP Monographs: Hyperici herba. Exeter: European Scientific Cooperative on Phytotherapy.Google Scholar
Dajoz, R (1992) Some aspects of the relations between plants and insects: Their significance in the dynamics of phytophagous insect populations. Cahiers des Naturalistes 48, 87–103.Google Scholar
Demisch, L, Hölzl, J, Gollnik, B & Kaczmarczyk, P (1989) Identification of selective MAO-type-A inhibitors in Hypericum perforatum L. (Hyperforat®). Pharmacopsychiatry 22, 194.Google Scholar
De Smet, PAGM, Keller, K, Hansel, R & Chandler, RFAdverse Effects of Herbal Drugs, vol. 3, p. 166. Berlin: Springer-Verlag.Google Scholar
Dimpfel, W, Schober, F & Mannel, M (1998) Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St John's wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG). Pharmacopsychiatry 31,Suppl.30–35.CrossRefGoogle Scholar
Donath, F & Roots, I (1995) Untersuchung zur erfassung der wirkung von baldrian-extrakt LI 156 auf das pharmako-EEG bei 16 probanden (Investigation of the effects of Valerian extract LI156 on the EEG of 16 subjects). Zeitschrift für Phytotherapie Abstractband 10–11.Google Scholar
Dorn, M (1989) Milderung grippaler effekte durch ein pflanzliches immunstimulans (Alleviation of flu-like effects through plant-based immunostimulants). Natur- und Ganzheitsmedizin 2, 314–319.Google Scholar
Douglas, J (1993) Valerian—Valeriana officinalis L. Christchurch, NZ: The New Zealand Institute for Crop & Food Research Limited.Google Scholar
Dressing, H, Kohler, S & Muller, WE (1996) Improvement of sleep quality with a high-dose valerian/balm preparation. Psychopharmakotherapie 3, 123–130.Google Scholar
Dressing, H, Riemann, D, Low, H, Schredl, M, Reh, C, Laux, P & Muller, WE (1992) Valerian–melisse combinations versus benzodiazepines in the treatment of insomnia. Therapiewoche 42, 726–736.Google Scholar
Dweck, AC (1997) An introduction to valerian Valeriana officinalis and related species. In Valerian. The genus Valeriana, pp. 16–35 [ Houghton, PJ, editor]. Amsterdam: Hardwood Academic Publishers.Google Scholar
Eder, M & Mehnert, W (1998) Bedeutung pflanzlicher begleitstoffe in extrakten (Meaning of botanical co-substances in extracts). Pharmazie 53, 285–293.Google Scholar
Eickstedt, KW & Rahmann, S (1969) Psychopharmakologische wirkungen von valepotriaten (Psychopharmacological activity of valepotriates). Arzneimittelforschung 19, 316–319.Google Scholar
Ellingwood, F (1993) American Materia Medica, Therapeutics and Pharmacognosy, vol. 2, pp. 358–376. Portland, OR: Eclectic Medical Publications.Google Scholar
Elsasser-Beile, U, Willenbacher, W, Bartsch, HH, Gallati, H, Monting, JS & Von Kleist, S (1996) Cytokine production in leukocyte cultures during therapy with Echinacea extract. Journal of Clinical Laboratory Analysis 10, 441–445.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Erdelmeier, CAJ (1998) Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. Pharmacopsychiatry 31, suppl., 2–6.CrossRefGoogle ScholarPubMed
European Pharmacopoeia 1996 3rd ed., pp. 1702–1703. Strasbourg: European Department for the Quality of Medicines within the Council of Europe.Google Scholar
Evstatieva, LN, Hanjieva, NV, Popov, SS & Pashankov, PI (1993) A biosystematic study of Valeriana officinalis (Valerianaceae) distributed in Bulgaria. Plant Systematics and Evolution 185, 167–179.CrossRefGoogle Scholar
Facino, RM, Carini, M, Aldini, G, Marinello, C, Arlandini, E, Franzoi, L, Colombo, M, Pietta, P & Mauri, P (1993) Direct characterization of caffeoyl esters with antihyaluronidase activity in crude extracts from Echinacea angustifolia roots by fast atom bombardment tandem mass spectrometry. Farmaco 48, 1447–1461.Google ScholarPubMed
Falk, H & Schmitzberger, W (1992) On the nature of “soluble” hypericin in Hypericum species. Monatschefte für Chemie 123, 731–739.CrossRefGoogle Scholar
Fauteck, JD (1996) Interaction of Valeriana officinalis with melatonin receptors. A possible explanation of its biological action. 2nd International Congress on Phytomedicine, Sept 11–14, Munich: Abstract SL-56.Google Scholar
Felter, HW & Lloyd, JU (1983) King's American Dispensatory, 18th ed., 3rd revision, vol. 2, 1905 (reprinted). Portland, OR: Eclectic Medical Publications.Google Scholar
Ferreira, F, Santos, MS, Faro, C, Pirres, E, Carvalho, AP, Cunha, AP & Macedo, T (1996) Effect of extracts of Valeriana officinalis on [3H]GABA. Release in synaptosomes: Further evidence for the involvement of free GABA in the valerian-induced release. Revista Portuguesa de Farmacia 46, 74–77.Google Scholar
Franchomme, P & Penoel, D (1990) L'aromathérapie exactement: Encyclopédie de l'utilisation thérapeutique des huiles essentielles (The concise aromatherapy: Encyclopedia of the therapeutic uses of essential oils), p. 358. Limoges: R. Jollois.Google Scholar
Friede, M, Tegtmeier, M, Willigmann, I, Harnischfeger, G & Wüstenberg, P (1998) Clinical efficacy of Hypericum perforatum containing low amounts of hyperforin. 46th Annual Congress of the Society for Medicinal Plant Research, J27, Vienna.Google Scholar
Gaedcke, F (1997) Herstellung, Qualität, Analytik und Anwendung von Johanniskraut-Extrakten (Production, quality, analysis and use of St John's wort). Zeitschrift für Arznei-& Gewürzpflanzen 2, 63–72.Google Scholar
Gerhard, U, Linnenbrink, N, Georghiadou, C & Hobi, V (1996) Vigilance-decreasing effects of 2 plant-derived sedatives. Schweizerische Rundschau für Medizin Praxis 85, 473–481.Google Scholar
Grieve, MA (1971) Modern Herbal, vol. 1. New York, NY: Dover Publications.Google Scholar
Grieve, MA (1971) Modern Herbal, vol. 2. New York, NY: Dover Publications.Google Scholar
Grieve, MA (1980) A Modern Herbal. Harmondsworth, Middlesex: Penguin.Google Scholar
Grimwald, J & Buttel, K (1996) The European phytotherapeutics market. Figures, trends, analyses. Drugs Made in Germany 39, 6–11.Google Scholar
Halama, P (1991) Wirksamkeit des Johanniskrautextrakes LI 160 bei depressiver Verstimmung (Activity of St John's wort extract LI 160 in depressive illness). Nervenheilkunde 10, 250–253.Google Scholar
Hansel, R & Schulz, J (1982) Valerenic acid derivatives from European Valeriana roots: detection and assay by HPLC. Deutsche Apotheker Zeitung 122, 215–219.Google Scholar
Hansgen, KD, Vesper, J & Ploch, M (1994) Multi-center double-blind study examining the antidepressant effectiveness of the Hypericum extract LI 160. Journal of Geriatric Psychiatry and Neurology 7,Suppl.15–18.CrossRefGoogle Scholar
Harborne, JB (1993) Advances in Chemical Ecology. Natural Product Reports 10, 327–348.CrossRefGoogle Scholar
Harrer, G, Hubner, WD & Podzuweit, H (1994) Effectiveness and tolerance of the Hypericum extract LI 160 compared to maprotiline: a multi-centre double-blind study. Journal of Geriatric Psychiatry and Neurology 7,Suppl.1, 24–28.CrossRefGoogle Scholar
Harrer, G, Schmidt, U, Kuhn, U & Biller, A (1999) Comparison of equivalence between the St John's wort extract LoHyp-57 and Fluoxetin. Arzneimittel-Forschung/Drug Research 49, 289–296.Google Scholar
Hendriks, H, Bos, R, Woerdenbag, HJ & Koster, AS (1985) Central nervous depressant activity of valerenic acid in the mouse. Planta Medica 51, 28–31.Google Scholar
Hendriks, H, Geertsma, HJ & Malingre, TM (1981) The occurrence of valeranone and crypto-fauronol in the essential oil of Valeriana officinalis L. s.l. collected in the northern part of The Netherlands. Pharmaceutisch Weekblad 116, 1316–1320.CrossRefGoogle Scholar
Herberg, KW (1994) Testing of psychotropic herbaceous agents: Alternative to psychopharmacotherapy?. Therapiewoche 44, 704–713.Google Scholar
Hiller, KO & Rahlfs, V (1995) Therapeutic comparison of a phytocombination with amitriptylin. Forschende Komplementärmedizin 2, 123–132.Google Scholar
Hiller, K & Zetler, G (1996) Neuropharmacological studies on ethanol extracts of Valeriana officinalis L.: Behavioural and anticonvulsant properties. Phytotherapy Research 10, 145–151.Google Scholar
Hobbs, C (1989) The Echinacea Handbook. Portland, OR: Eclectic Medical Publications.Google Scholar
Hoheisel, O, Sandberg, M, Bertram, S, Bulitta, M & Schäfer, M (1997) Echinacea treatment shortens the course of the common cold: a double-blind, placebo-controlled clinical trial. European Journal of Clinical Research 9, 261–269.Google Scholar
Holzl, J, Demisch, L & Gollinik, B (1989) Investigations about antidepressive and mood changing effects of Hypericum perforatum. Planta Medica 55, 643.Google Scholar
Houghton, PJ (1997) The chemistry of Valeriana. In Valerian. The Genus Valeriana, pp. 21–54 [Houghton, PJ, editor]. Amsterdam: Hardwood Academic.Google Scholar
Hubner, WD, Lande, S & Podzuweit, H (1994) Hypericum treatment of mild depression with somatic symptoms. Journal of Geriatric Psychiatry and Neurology 7,Suppl. 1, 12–15.CrossRefGoogle ScholarPubMed
Inderijit, (1996) Plant phenolics in allelopathy. Botanical Review 62, 186–202.CrossRefGoogle Scholar
Inoue, M (1992) Allelochemicals from Polygonum sachalinense Fr. Schm. (Polygonaceae). Journal of Chemical Ecology 18, 1833–1840.Google Scholar
Jansen, W (1977) Doppelblindstudie mit baldrisedon (Double-blind study with baldrisedon). Therapiewoche 27, 2779–2786.Google Scholar
Jansen, MAK, Gaba, V & Greenberg, BM (1998) Higher plants and UV-B radiation: balancing damage, repair and acclimation. Trends in Plant Science 3, 131–135.CrossRefGoogle Scholar
Jung, HD & Schröder, H (1954) Archives of Dermatology of Syphilis 197, 130–144.Google Scholar
Jurcic, K, Melchart, D, Holzmann, M, Martin, P, Bauer, R, Doenecke, A & Wagner, H (1989) Two proband studies for the stimulation of granulocyte phagocytosis by Echinacea-containing preparations. Zeitschrift für Phytotherapie 10, 67–70.Google Scholar
Kamm-Kohl, AV, Jansen, W & Brockann, P (1984) Modern valerian therapy against nervous disorders in senium. Medizinische Welt 35, 1450–1455.Google Scholar
Kerb, R, Brockmuller, J, Staffeldt, B, Ploch, M & Roots, I (1996) Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin. Antimicrobial Agents and Chemotherapy 40, 2087–2093.CrossRefGoogle ScholarPubMed
Keung, W, Lazo, O, Kunze, L & Vallee, BL (1996) Potentiation of the bioavailability of daidzin by an extract of Radix puerariae. Proceedings of the National Academy of Science, USA 93, 4284–4288.CrossRefGoogle ScholarPubMed
Kinkel, HJ, Plate, M & Tullner, HU (1984) Effect of Echinacin(TM) ointment in healing of skin lesions. Medizinische Klinik 79, 580–583.Google Scholar
Kisa, K, Sasaki, K, Yamaguchi, K & Kuwano, S (1981) Potentiating effect of sennoside C on purgative activity of sennoside A in mice. Planta Medica 42, 302–312.CrossRefGoogle ScholarPubMed
Kleber, E, Obry, T, Hippeli, S, Schneider, W & Elstner, EF (1999) Biochemical activities of extracts from Hypericum perforatum L. Arzneimittelforschung 49, 106–109.Google Scholar
Kniebel, R & Burchard, JM (1988) Antidepressive therapy in practice. Zeitschrift für Allgemeinmedizin 64, 689–696.Google Scholar
Kohnen, R & Oswald, WD (1988) The effects of valerian, propranolol, and their combination on activation performance, and mood of healthy volunteers under social stress conditions. Pharmacopsychiatry 21, 447–448.CrossRefGoogle ScholarPubMed
Krause, M (1984) Dissertation, cited in Bauer R & Wagner H (1991) Echinacea Species as Potential Immunostimulatory Drugs. In Economic and Medicinal Plant Research, vol. 5, pp. 291–292 [Wagner, H and Farnsworth, NR, editors]. London: Academic Press.Google Scholar
Kuc, J & Rush, JS (1985) Phytoalexins. Archives of Biochemistry and Biophysics 236, 455–472.Google Scholar
Laakmann, G, Schüle, C, Baghai, T & Kieser, M (1998) St John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31,Suppl. 1, 54–59.CrossRefGoogle ScholarPubMed
Langenheim, HJ (1994) Higher plant terpenoids: A phytocentric overview of their ecological roles. Journal of Chemical Ecology 20, 1223–1280.Google Scholar
Leathwood, PD & Chauffard, F (1985) Aqueous extract of valerian reduces latency to fall asleep in man. Planta Medica 51, 144–148.Google Scholar
Leathwood, PD, Chauffard, F & Munoz-Bos, R (1982) Effect of Valeriana officinalis L. on subjective and objective sleep parameters. Sleep 1982. 6th European Congress on Sleep Research, Zurich, pp. 402–405. Basel: Karger.Google Scholar
Leung, AY & Foster, S (1996) Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics, 2nd ed., pp. 216–219. New York, NY: John Wiley.Google Scholar
Leuschner, J, Muller, J & Rudmann, M (1993) Characterisation of the central nervous depressant activity of a commercially available valerian root extract. Arzneimittelforschung 43, 638–641.Google Scholar
Lindahl, O & Lindwall, L (1989) Double blind study of a valerian preparation. Pharmacology, Biochemistry and Behavior 32, 1065–1066.CrossRefGoogle ScholarPubMed
Linde, K, Ramirez, G, Mulrow, CD, Pauls, A, Weidenhammer, W & Melchart, D (1996) St John's wort for depression—an overview and meta-analysis of randomised clinical trials. British Medical Journal 313, 253–258.CrossRefGoogle ScholarPubMed
Luettig, B, Steinmüller, C, Gifford, GE, Wagner, H & Lohmann-Matthes, ML (1989) Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. Journal of the National Cancer Institute 81, 669–675.CrossRefGoogle ScholarPubMed
Lust, JB (1974) The Herb Book, p. 177. New York, NY: Bantam Books.Google Scholar
Macias, FA (1993) Allelochemicals from Pilocarpus goudotianus leaves. Journal of Chemical Ecology 19, 1371–1379.CrossRefGoogle Scholar
May, G & Willuhn, G (1978) Antiviral effect of aqueous plant extracts in tissue culture. Arzneimittelforschung 28, 1–7.Google ScholarPubMed
Meissner, FK (1987) Experimental studies on the action of extracts of herba recens Echinacea purpureae on skin flaps. Arzneimittelforschung 37, 17–18.Google ScholarPubMed
Melzer, R, Fricke, U & Holzl, J (1991) Vasoactive properties of procyanidins from Hypericum perforatum L. in isolated porcine coronary arteries. Arzneimittelforschung 41, 481–483.Google ScholarPubMed
Mennini, T, Bernasconi, P, Bombardelli, E & Morazzoni, P (1993) In vitro study on the interaction of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine and barbiturate receptors in rat brain. Fitoterapia 64, 291–300.Google Scholar
Mitchell-Olds, T, Gershenzon, J, Baldwin, I & Boland, W (1998) Chemical ecology in the molecular area. Trends in Plant Science 3, 362–364.CrossRefGoogle Scholar
Monmaney, T (1998) Labels' potency claims often inaccurate, analysis finds. The Los Angeles Times, August 31, A10.Google Scholar
Muller, WE, Rolli, M, Schafer, C & Hafner, U (1997) Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry 30,Suppl. 2102–107.Google Scholar
Muller, WE, Singer, A, Wonnemann, M, Hafner, U, Rolli, M & Schafer, C (1998) Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 31,Suppl., 16–21.Google Scholar
Mullins, RJ (1998) Echinacea—associated anaphylaxis. Medical Journal of Australia 168, 170–171.Google Scholar
Nahrstedt, A (1989) The significance of secondary metabolites for interactions between plants and insects. Planta Medica 55, 333–338.CrossRefGoogle Scholar
Nemeroff, CB (1998) The neurobiology of depression. Scientific American 278, 42–49.Google Scholar
Nielsen, M, Frokjaer, S & Braestrup, C (1988) High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro. Biochemical Pharmacology 37, 3285–3287.Google Scholar
Niesel, S & Schilcher, H (1990) Vergleich der Freisetzung von Hypericin und Pseudohypericin in Abhängigkeit verschiedener Extraktionsbedingungen (Comparison of the liberation of hypericin and pseudohypericin in relation to various different extraction methods). Archives der Pharmazie 323, 755.Google Scholar
Obry, T (1996) Diploma, cited in Scientific Committee of ESCOP. ESCOP Monographs: Hyperici herba. Exeter: European Scientific Cooperative on Phytotherapy.Google Scholar
Onawunmi, GO, Yisak, W & Ogunlana, EO (1984) Antibacterial constituents in the essential oil of Cymbopogon citratus (DC.) Stapf. Journal of Ethnopharmacology 12, 279–286.CrossRefGoogle ScholarPubMed
Orinda, D, Diederich, J & Wacker, A (1973) Antiviral activity of components of Echinacea purpurea. Arzneimittelforschung 23, 1119–1120.Google Scholar
Panijel, M (1985) Treatment of moderately severe anxiety states. Therapiewoche 35, 4659–4668.Google Scholar
Pengelly, A (1996) The Constituents of Medicinal Plants: An Introduction to the Chemistry & Therapeutics of Herbal Medicines. Muswellbrook: Sunflower Herbals.Google Scholar
Perovic, S & Muller, WE (1995) Pharmacological profile of hypericum extract. Effect on serotonin uptake by postsynaptic receptors. Arzneimittelforschung 45, 1145–1148.Google Scholar
Perry, NB, van Klink, JW, Burgess, EJ & Parmenter, GA (1997) Alkamide levels in Echinacea purpurea (L.) Moench: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers. Planta Medica 63, 58–62.CrossRefGoogle ScholarPubMed
Quandt, J (1994) Therapie ängstlich-depressive verstimmungen. Phyto-kombinationen hellen die psyche auf (Therapy for anxiety-depressive conditions. Phyto-combinations lift the spirits). Therapiewoche 44, 292–299.Google Scholar
Quandt, J, Schmidt, U & Schenk, N (1993) Ambulante Behandlung leichter und mittelschwerer depressiver Verstimmungen (Out-patient treatment of mild to moderate depression). Der Allgemeinarzt 2, 97–102.Google Scholar
Reitz, HD (1990) Immunomodulation mit pflanzlichen wirkstoffen: eine wissenschaftliche studie am beispiel esberitox N. (Immunomodulation with botanical substances: a scientific study using esberitox N). Notabene Medici 20, 362–366.Google Scholar
Reuter, HD (1997) Phytotherapy—Herbal Medicine in the Twenty-first Century. Proceedings of the Symposium presented by the College of Practitioners of Phytotherapy, London, 17–18 May 1997. East Sussex: The School of Phytotherapy.Google Scholar
Samochowiec, E, Urbanska, L, Manka, W & Stolarska, E (1979) Evaluation of the effect of Calendula officinalis and Echinacea angustifolia extracts on Trichomonas vaginalis in vitro. Wiadomosci Parazytologiczne 25, 77–81.Google ScholarPubMed
Santos, MS, Ferreira, F, Cunha, AP, Carvalho, AP & Macedo, T (1994) An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Medica 60, 278–279.CrossRefGoogle ScholarPubMed
Santos, MS, Ferriera, F, Cunha, AP, Carvalho, AP, Ribeiro, CF & Macedo, T (1994) Synaptosomal GABA release as influenced by valerian root extract—involvement of the GABA carrier. Archives Internationales de Pharmacodynamie et de Therapie 327, 220–231.Google Scholar
Schmidt, U, Albrecht, M & Schenk, N (1990) Immunstimulans senkt häufigkeit grippaler infekte. Plazebokontrollierte doppelblindstudie mit 646 studenten der Kölner Universität (Immunostimulation dramatically lowers rates of flu infections. Placebo-controlled double-blind study of 646 students from Cologne University). Natur- und Ganzheitsmedizin 3, 277–281.Google Scholar
Schmidt-Voigt, J (1986) Treatment of nervous sleep disorders and unrest with a sedative of purely vegetable origin. Therapiewoche 36, 663–667.Google Scholar
Schneider, G & Willems, M (1982) Weitere Erkenntnisse uber die Abbauprodukte der Valepotriate aus Kentranthus ruber (L.) DC (Further observations on the by-products of Centrathus ruber Valepotriates). Archives der Pharmazie 315, 691–697.CrossRefGoogle Scholar
Schulte, KE, Rucker, G & Perlick, J (1967) The presence of polyacetylene compounds in Echinacea purpura Mnch and Echinacea angustifolia DC. Arzneimittelforschung 17, 825–829.Google Scholar
See, DM, Broumand, N, Sahl, L & Tilles, JG (1997) In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 35, 229–235.Google Scholar
Sharp, R (1997) Echinacea a danger to asthmatics Medical Observer 8, 08, 1.Google Scholar
Smeh, NJ (1995) Creating Your Own Cosmetics—Naturally. Garrisonville, VA: Alliance Publishing.Google Scholar
Sommer, H & Harrer, G (1994) Placebo-controlled double-blind study examining the effectiveness of an Hypericum preparation in 105 mildly depressed patients. Journal of Geriatric Psychiatry and Neurology 7,Suppl. 1, 9–11.Google Scholar
Staffeldt, P, Kerb, R, Brockmöller, J, Ploch, M & Roots, I (1993) Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers. Nervenheilkunde 12, 331–338.Google Scholar
Steger, W (1985) Depressive verstimmungen—randomisierte doppelblindstudie zum wirksamkeitsvergleich einer pflanzlichen wirkstoffkombination und eines synthetischen antidepressivums (Depressive conditions–comparative random double-blind study of the efficacy of a botanical combination and of a synthetic anti-depressant). Zeitschrift für Allgemeinmedizin 61, 914–918.Google Scholar
Stimpel, M, Proksch, A, Wagner, H & Lohmann-Matthes, ML (1984) Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea. Infection and Immunity 46, 845–849.Google Scholar
Stoll, A, Renz, J & Brack, A (1950) Isolation and constitution of echinacoside, a glycoside from the roots of Echinacea angustifolia DC. Helvetia Chimica Acta 33, 1877–1893.Google Scholar
Stuart, DL & Wills, RBH (1999) Alkylamide and cichoric acid levels in plant sections of Echinacea purpurea during growth. Journal of Herbs, Spices and Medicinal Plants 7, (In the Press).Google Scholar
Teufel-Mayer, R & Gleitz, J (1997) Effects of long-term administration of hypericum extracts on the affinity and density of the central serotonergic 5-HT1 A and 5-HT2 A receptors. Pharmacopsychiatry 30, Suppl., 113–116.Google Scholar
Thiede, HM & Walper, A (1993) MAO- and COMT-inhibition by hypericum extracts and hypericin. Nervenheilkunde 12, 346–348.Google Scholar
Thiele, B, Brink, I & Ploch, M (1993) Modulation of the cytokine expression by hypericum extract. Nervenheilkunde 12, 353–356.Google Scholar
Tubaro, A, Tragni, E, Del Negro, P, Galli, CL & Della Loggia, R (1987) Anti-inflammatory activity of a polysaccharide fraction of Echinacea angustifolia. Journal of Pharmacy and Pharmacology 39, 567–569.CrossRefGoogle ScholarPubMed
Tufik, S, Fujita, K, Seabra M de, L & Lobo, LL (1994) Effects of a prolonged administration of valepotriates in rats on the mothers and their offspring. Journal of Ethnopharmacology 41, 39–44.Google Scholar
Tyler, VE, Brady, LR & Robbers, JE (1988), Pharmacognosy, 9th ed. Philadelphia, PA: Lea & Febiger.Google Scholar
USP Drug Information. (1998) US Pharmacopeia Patient Leaflet. Valerian (Oral). Rockville, MD: The United States Pharmacopeial Convention.Google Scholar
Verpoorte, R (1998) Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discovery Today 3, 232–238.CrossRefGoogle Scholar
von der Hude, W, Scheutwinkel-Reich, M & Braun, R (1986) Bacterial mutagenicity of the tranquilizing constituents of Valerianaceae roots. Mutation Research 169, 23–27.Google Scholar
Wacker, A & Hilbig, W (1978) Virus-inhibition by echinacea purpurea. Planta Medica 33, 89–102.Google Scholar
Wagner, H & Bladt, S (1996) Plant Drug Analysis: A Thin Layer Chromatography Atlas, 2nd ed., p. 58. Berlin: Springer-Verlag.Google Scholar
Wagner, H, Breu, W, Willer, F, Wierer, M, Remiger, P & Schwenker, G (1989) In vitro inhibition of arachidonate metabolism by some alkamides and prenylated phenols. Planta Medica 55, 566–567.Google Scholar
Wagner, H & Jurcic, K (1989) In vitro- and vivo-metabolism of 14C-didrovaltrate. Planta Medica 38, 366–376.Google Scholar
Wagner, H & Jurcic, K (1991) Immunologic studies of plant combination preparations. In-vitro and in-vivo studies on the stimulation of phagocytosis. Arzneimittelforschung 41, 1072–1076.Google ScholarPubMed
Wagner, H, Jurcic, K & Schaette, R (1980) Comparative studies on the sedative action of Valeriana extracts, valepotriates and their degradation products. Planta Medica 39, 358–365.CrossRefGoogle ScholarPubMed
Wagner, H, Proksch, A, Riess-Maurer, I, Vollmar, A, Odenthal, S, Stuppner, H, Jurcic, K, Le Turdu, M & Fang, JN (1985) Immunostimulating action of polysaccharides (heteroglycans) from higher plants. Arzneimittelforschung 35, 1069–1075.Google ScholarPubMed
Wildfeuer, A & Mayerhofer, D (1994) The effects of plant preparations on cellular functions in body defense. Arzneimittelforschung 44, 361–366.Google ScholarPubMed
Willey, LB, Mady, SP, Cobaugh, DJ & Wax, PM (1995) Valerian overdose: a case report. Veterinary and Human Toxicology 37, 364–365.Google Scholar
Williams, DH, Stone, MJ, Hauck, PR & Rahman, SK (1989) Why are secondary metabolites (natural products) biosynthesized?. Journal of Natural Products 52, 1189–1208.Google Scholar
Wills, RBH & Stuart, DL (1998) Levels of active constituents in manufactured echinacea products. Chemistry Australia no. 9, 17–19.Google Scholar
Wills, RBH & Stuart, DL (1999 a) Generation of High Quality Australian Echinacea Purpurea Products. Kingston ACT, Australia: Rural Industries Research and Development Corporation.Google Scholar
Wills, RBH & Stuart, DL (1999 b) Alkylamide and cichoric acid levels in Echinacea purpurea grown in Australia. Food Chemistry 67, 385–388.Google Scholar
Woerdenbag, HJ, Bos, R & Scheffer, JJC (1997) Valerian: quality assurance of the crude drug and its preparations. In Valerian. The Genus Valeriana pp. 101–128. [ Houghton, PJ, editor]. Amsterdam: Hardwood Academic Publishers.Google Scholar
Zimmer, M (1985) Special conservative therapy of acute sinusitis in the ENT practice. Therapiewoche 35, 4024–4028.Google Scholar